Company: LGN
Filing Date: 2025-11-03
Form Type: DRS
Source: 0001193125-25-262782
Chunk: 323

Company: Legence Corp.
Filing Date: 2025-11-03
Form: DRS
Chunk 323
---
 the assets of the Company.

Advances, including standby letters of credit, under the revolving line of credit agreement
may be elected to be treated as either SOFR rate loans or base rate loans. SOFR rate loans bear interest at SOFR plus 3.50% to 4.00% based on the Company’s Net Leverage Ratio, with a SOFR floor of 0%, and base rate loans bear interest at 2.50%
to 3.00% plus the base rate, which is the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate and (c) the SOFR rate for one month plus 1.00%. Interest on base rate loans is payable quarterly. Interest on SOFR rate loans is
payable based on the selected interest period if less than three months or quarterly if the selected interest period is three months or longer. In addition, a revolver commitment fee is payable quarterly for

F-73

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

the unused portion of the revolving line of credit at a rate of 0.38% to 0.50% based on the Company’s Net Leverage Ratio. As of June 30, 2025, the rate for the unused portion of the
revolving line of credit is 0.50%. The revolving line of credit may be used to issue standby letters of credit, which reduce the available borrowings. As of June 30, 2025, there were $5.2 million letters of credit outstanding under the
revolving line of credit, with an interest rate of 4.13%.

As of June 30, 2025, $84.8 million was available to be borrowed under
the revolving line of credit. There were no borrowings under the revolving line of credit as of June 30, 2025 or December 31, 2024.

The Company’s revolving line of credit agreement, in addition to customary affirmative covenants, contains a financial covenant that
requires the Consolidated First Lien Net Leverage Ratio to be less than 8.50 to 1.00. The Net Leverage Ratio is only tested if as of the last day of a Test Period (generally quarterly) the amount of loans and/or letters of credit outstanding under
the revolving line of credit is greater than 35% of the facility size.